At LeafN, we specialize in cultivating premium- grade medical cannabis for global distribution. Our strain portfolio is carefully curated and bred to meet the highest international standards for pharmaceutical use, ensuring therapeutic efficacy and consistency across every batch
Our state-of-the-art indoor cultivation facility comprises three fully controlled flowering chambers, each engineered to maintain precise environmental parameters. Depending on cultivar genetics and optimized cultivation protocols, each chamber consistently yields between 60 to 70 kilograms of pharmaceutical-grade dried cannabis flower per cycle. This output reflects our commitment to consistency, traceability, and adherence to global GACP and EU GMP-Compliant standards.
We employ advanced cloning techniques using certified seeds to develop and stabilize new cultivars. Each phenotype is selected for its unique cannabinoid and terpene profile, contributing to a diverse and market-responsive product offering.
Our comprehensive traceability system ensures that every strain can be tracked from cultivation to final product. Each batch is linked to its original Strain Certificate of Analysis (COA) via an integrated QR code, reinforcing our commitment to transparency and regulatory compliance.
Our cultivation program includes a wide range of Sativa-dominant, Indica-dominant, and Hybrid strains. These cultivars are distinguished by their rich terpene profiles, refined flavor characteristics, and potent therapeutic effects designed to meet the diverse needs of medical cannabis patients.
Our dedicated drying chambers are engineered to maintain precise control over humidity and temperature levels. This post-harvest environment safeguards cannabinoid and terpene integrity while preventing microbial contamination such as mold or mildew.
At LeafN, all dried flower undergoes careful hand trimming, a deliberate choice to maintain pharmaceutical-grade quality and integrity across every batch.
